Citations (66)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Andrew J Thompson & Sarah CR Lummis. (2007) The 5-HT3 receptor as a therapeutic target. Expert Opinion on Therapeutic Targets 11:4, pages 527-540.
Read now
Read now
Articles from other publishers (65)
Xiuxiu Liao, Binbin Ye, Wanting Hu, Jinyuan Han, Yaozhong Zhao, Yongzhao Dai, Xipei Wu, Ziyao Mo, Ling Wei & Ke Nie. (2024) Xiaobanxia decoction alleviates chemotherapy-induced nausea and vomiting by inhibiting GSDME-mediated pyroptosis. Journal of Ethnopharmacology 318, pages 116970.
Crossref
Crossref
Josselin Corzo-Gómez, Ofir Picazo, Manuela Castellanos-Pérez & Alfredo Briones-Aranda. (2023) Systematic Review of the Serotonergic System in the Pathophysiology of
Severe Dengue: The Theory of Thrombocytopenia and Vascular Extravasation. Mini-Reviews in Medicinal Chemistry 23:2, pages 230-243.
Crossref
Crossref
Jorge Correale, Reinhard Hohlfeld & Sergio E. Baranzini. (2022) The role of the gut microbiota in multiple sclerosis. Nature Reviews Neurology 18:9, pages 544-558.
Crossref
Crossref
Tahereh Eteraf-Oskouei & Moslem Najafi. (2022) The relationship between the serotonergic system and COVID-19 disease: A review. Heliyon 8:5, pages e09544.
Crossref
Crossref
Aleksandra Suchanecka, Jolanta Chmielowiec, Krzysztof Chmielowiec, Grzegorz Trybek, Aleksandra Jaroń, Wojciech Czarny, Paweł Król, Jolanta Masiak & Anna Grzywacz. (2022) Serotonin Receptor HTR3A Gene Polymorphisms rs1985242 and rs1062613, E-Cigarette Use and Personality. International Journal of Environmental Research and Public Health 19:8, pages 4746.
Crossref
Crossref
Shinhui Lee, Hee-Soo Seol, Sanung Eom, Jaeeun Lee, Chaelin Kim, Jong-Hwan Park, Tae-Hwan Kim & Junho H. Lee. (2022) Hydroxy Pentacyclic Triterpene Acid, Kaempferol, Inhibits the Human 5-Hydroxytryptamine Type 3A Receptor Activity. International Journal of Molecular Sciences 23:1, pages 544.
Crossref
Crossref
Ahmad Qasem, Abed Elrahman Naser & Saleh A. Naser. (2021) Enteropathogenic infections modulate intestinal serotonin transporter (SERT) function by activating Toll-like receptor 2 (TLR-2) in Crohn’s disease. Scientific Reports 11:1.
Crossref
Crossref
Helen Irving, Ilona Turek, Christine Kettle & Nor Yaakob. (2021) Tapping into 5-HT3 Receptors to Modify Metabolic and Immune Responses. International Journal of Molecular Sciences 22:21, pages 11910.
Crossref
Crossref
Kuan-Wen Su, Wayne G. Shreffler & Qian Yuan. (2021) Gastrointestinal immunopathology of food protein–induced enterocolitis syndrome and other non-immunoglobulin E–mediated food allergic diseases. Annals of Allergy, Asthma & Immunology 126:5, pages 516-523.
Crossref
Crossref
Yuting Chen, Jingkang Sun, Xiude Fan, Xiaoyun Wang, Lu Zeng, Xiaoge Zhang, Kun Zhang, Na Li, Qunying Han & Zhengwen Liu. (2021) Association of 5-Hydroxytryptamine 3 Receptor Antagonists With the Prognosis of Liver Failure. Frontiers in Pharmacology 12.
Crossref
Crossref
Nicholas M. Barnes, Gerard P. Ahern, Carine Becamel, Joël Bockaert, Michael Camilleri, Severine Chaumont-Dubel, Sylvie Claeysen, Kathryn A. Cunningham, Kevin C. Fone, Michael Gershon, Giuseppe Di Giovanni, Nathalie M. Goodfellow, Adam L. Halberstadt, Rachel M. Hartley, Ghérici Hassaine, Katharine Herrick-Davis, Ruud Hovius, Enza Lacivita, Evelyn K. Lambe, Marcello Leopoldo, Finn Olav Levy, Sarah C. R. Lummis, Philippe Marin, Luc Maroteaux, Andrew C. McCreary, David L. Nelson, John F. Neumaier, Adrian Newman-Tancredi, Hugues Nury, Alexander Roberts, Bryan L. Roth, Anne Roumier, Gareth J. Sanger, Milt Teitler, Trevor Sharp, Carlos M. Villalón, Horst Vogel, Stephanie W. Watts & Daniel Hoyer. (2020) International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function. Pharmacological Reviews 73:1, pages 310-520.
Crossref
Crossref
Radomir Juza, Premysl Vlcek, Eva Mezeiova, Kamil Musilek, Ondrej Soukup & Jan Korabecny. (2020)
Recent advances with 5‐HT
3
modulators for neuropsychiatric and gastrointestinal disorders
. Medicinal Research Reviews 40:5, pages 1593-1678.
Crossref
Crossref
M. G. Marrero, S. L. Field, A. L. Skibiel, B. Dado-Senn, J. P. Driver & J. Laporta. (2020) Increasing serotonin bioavailability alters gene expression in peripheral leukocytes and lymphoid tissues of dairy calves. Scientific Reports 10:1.
Crossref
Crossref
Mahdieh Kabiri, Anahid Hemmatpour, Fatemeh Zare, Hossein Hadinedoushan & Alireza Karimollah. (2020) Paroxetine modulates immune responses by activating a JAK2/STAT3 signaling pathway. Journal of Biochemical and Molecular Toxicology 34:5.
Crossref
Crossref
Qi Meng, QianQian Cheng, Xiaodi Feng, Siqi Chen, Yaqi Li, Guanglong Zhang & Ke Nie. (2020) The Antiemetic Effect of Xiao-Ban-Xia-Tang Formula against Cisplatin-Induced Emesis is Mediated through Inhibition of NLRP3 Inflammasome Activation in a Rat Pica Model. Evidence-Based Complementary and Alternative Medicine 2020, pages 1-19.
Crossref
Crossref
Ana M. Martins, Andreia Ascenso, Helena M. Ribeiro & Joana Marto. (2020) The Brain–Skin Connection and the Pathogenesis of Psoriasis: A Review with a Focus on the Serotonergic System. Cells 9:4, pages 796.
Crossref
Crossref
Antonia G. Stuebler & Michaela Jansen. (2020) Bupropion Inhibits Serotonin Type 3AB Heteromeric Channels at Clinically Relevant Concentrations. Molecular Pharmacology 97:3, pages 171-179.
Crossref
Crossref
Ana Karen Sandoval-Talamantes, B.A. Gómez-González, D.F. Uriarte-Mayorga, M.A. Martínez-Guzman, Katia Alejandra Wheber-Hidalgo & Anabell Alvarado-Navarro. (2020) Neurotransmitters, neuropeptides and their receptors interact with immune response in healthy and psoriatic skin. Neuropeptides 79, pages 102004.
Crossref
Crossref
Mohammad Amini, Ehsan Saboory, Bagher Pourheydar, Morteza Bagheri & Roya Naderi. (2020) Involvement of endocannabinoid system, inflammation and apoptosis in diabetes induced liver injury: Role of 5-HT3 receptor antagonist. International Immunopharmacology 79, pages 106158.
Crossref
Crossref
Gohar Fakhfouri, Reza Rahimian, Jonas Dyhrfjeld-Johnsen, Mohammad Reza Zirak & Jean-Martin Beaulieu. (2019)
5-HT
3
Receptor Antagonists in Neurologic and Neuropsychiatric Disorders: The Iceberg Still Lies beneath the Surface
. Pharmacological Reviews 71:3, pages 383-412.
Crossref
Crossref
Zhenjiang Xia, Yifan Zhang, Cen Li, Yan Xu, Jinjin Dong, Lulu Wang, Qiangqiang He, Xiaoyan Zou, Huali Wu, Jichun Han, Minxuan Cai, Yuzhi Du, Lixin Wei & Jing Shang. (2019) Traditional Tibetan medicine Anzhijinhua San attenuates ovalbumin-induced diarrhea by regulating the serotonin signaling system in mice. Journal of Ethnopharmacology 236, pages 484-494.
Crossref
Crossref
Muhammad Harith Zulkifli, Praveena Viswenaden, Malina Jasamai, Norazrina Azmi & Nor Syafinaz Yaakob. (2019) Potential roles of 5-HT3 receptor (5-HT3R) antagonists in modulating the effects of nicotine. Biomedicine & Pharmacotherapy 112, pages 108630.
Crossref
Crossref
Shoma Mikawa, Makoto Kondo, Noriyuki Kaji, Taiki Mihara, Ryohei Yoshitake, Takayuki Nakagawa, Masaya Takamoto, Ryohei Nishimura, Shoichi Shimada, Hiroshi Ozaki & Masatoshi Hori. (2018)
Serotonin 3 receptor signaling regulates 5‐fluorouracil‐mediated apoptosis indirectly
via
TNF‐α production by enhancing serotonin release from enterochromaffin cells
. The FASEB Journal 33:2, pages 1669-1680.
Crossref
Crossref
Zhengjiang Liu, Zhiheng Zeng, Changdong Wu & Hua Liu. (2019) Tropisetron inhibits sepsis by repressing hyper-inflammation and regulating the cardiac action potential in rat models. Biomedicine & Pharmacotherapy 110, pages 380-388.
Crossref
Crossref
Yan YU, Wanhu ZHU, Qing LIANG, Jing LIU, Xu YANG & Guangchun SUN. (2018) Tropisetron attenuates lipopolysaccharide induced neuroinflammation by inhibiting NF-κB and SP/NK1R signaling pathway. Journal of Neuroimmunology 320, pages 80-86.
Crossref
Crossref
Yeu-Shiuan Su, Hao-Ruei Mei, Chun-Hung Wang & Wei-Hsin Sun. (2018) Peripheral 5-HT3 mediates mirror-image pain by a cross-talk with acid-sensing ion channel 3. Neuropharmacology 130, pages 92-104.
Crossref
Crossref
Sarah Lummis. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences
1
7
.
Stephanie A. Kleine & Steven C. Budsberg. (2017) Synovial membrane receptors as therapeutic targets: A review of receptor localization, structure, and function. Journal of Orthopaedic Research 35:8, pages 1589-1605.
Crossref
Crossref
Akash Pandhare, Aneesh Satya Pappu, Henrik Wilms, Michael Paul Blanton & Michaela Jansen. (2017) The antidepressant bupropion is a negative allosteric modulator of serotonin type 3A receptors. Neuropharmacology 113, pages 89-99.
Crossref
Crossref
Linjing Mu, Adrienne Müller Herde, Pascal M. Rüefli, Filippo Sladojevich, Selena Milicevic Sephton, Stefanie D. Krämer, Andrew J. Thompson, Roger Schibli, Simon M. Ametamey & Martin Lochner. (2016)
Synthesis and Pharmacological Evaluation of [
11
C]Granisetron and [
18
F]Fluoropalonosetron as PET Probes for 5-HT
3
Receptor Imaging
. ACS Chemical Neuroscience 7:11, pages 1552-1564.
Crossref
Crossref
María Emilia Di Rosso, María Laura Palumbo & Ana María Genaro. (2016) Immunomodulatory effects of fluoxetine: A new potential pharmacological action for a classic antidepressant drug?. Pharmacological Research 109, pages 101-107.
Crossref
Crossref
Hossein Amini-Khoei, Majid Momeny, Alireza Abdollahi, Ahmad Reza Dehpour, Shayan Amiri, Arya Haj-Mirzaian, Seyed Mohammad Tavangar, Seyed Hamid Ghaffari, Reza Rahimian & Shahram Ejtemaei Mehr. (2016) Tropisetron suppresses colitis-associated cancer in a mouse model in the remission stage. International Immunopharmacology 36, pages 9-16.
Crossref
Crossref
Gohar Fakhfouri, Kazem Mousavizadeh, Sharam Ejtemaei Mehr, Ahmad Reza Dehpour, Mohammad Reza Zirak, Jean-Eric Ghia & Reza Rahimian. (2014) From Chemotherapy-Induced Emesis to Neuroprotection: Therapeutic Opportunities for 5-HT3 Receptor Antagonists. Molecular Neurobiology 52:3, pages 1670-1679.
Crossref
Crossref
Toko Maehara, Kenjiro Matsumoto, Kazuhide Horiguchi, Makoto Kondo, Satoshi Iino, Shunji Horie, Takahisa Murata, Hirokazu Tsubone, Shoichi Shimada, Hiroshi Ozaki & Masatoshi Hori. (2015)
Therapeutic action of 5-HT
3
receptor antagonists targeting peritoneal macrophages in post-operative ileus
. British Journal of Pharmacology 172:4, pages 1136-1147.
Crossref
Crossref
Rodrigo Arreola, Enrique Becerril-Villanueva, Carlos Cruz-Fuentes, Marco Antonio Velasco-Velázquez, María Eugenia Garcés-Alvarez, Gabriela Hurtado-Alvarado, Saray Quintero-Fabian & Lenin Pavón. (2015) Immunomodulatory Effects Mediated by Serotonin. Journal of Immunology Research 2015, pages 1-21.
Crossref
Crossref
Nikolaos Christidis, Isabell Kang, Brian E Cairns, Ujendra Kumar, Xudong Dong, Annika Rosén, Sigvard Kopp & Malin Ernberg. (2014) Expression of 5-HT3 receptors and TTX resistant sodium channels (NaV1.8) on muscle nerve fibers in pain-free humans and patients with chronic myofascial temporomandibular disorders. The Journal of Headache and Pain 15:1.
Crossref
Crossref
Christian Stratz, John Anakwue, Harsharan Bhatia, Stefanie Pitz & Bernd L. Fiebich. (2014) Anti-inflammatory effects of 5-HT3 receptor antagonists in interleukin-1beta stimulated primary human chondrocytes. International Immunopharmacology 22:1, pages 160-166.
Crossref
Crossref
Brid Callaghan & John B. Furness. (2013) New Roles of Serotonin and Tachykinins in Intestinal Mucositis?. Digestive Diseases and Sciences 58:12, pages 3384-3385.
Crossref
Crossref
A. Aminian, F. Noorbakhsh, M. Ghazi-Khansari, L. Kafami, S. Javadi, G. Hassanzadeh, R. Rahimian, A.R. Dehpour & S.E. Mehr. (2013) Tropisetron diminishes demyelination and disease severity in an animal model of multiple sclerosis. Neuroscience 248, pages 299-306.
Crossref
Crossref
Amy S Newman, Nikolaos Batis, Gillian Grafton, Francesca Caputo, Catherine A Brady, Jeremy J Lambert, John A Peters, John Gordon, Keith L Brain, Andrew D Powell & Nicholas M Barnes. (2013)
5-Chloroindole: a potent allosteric modulator of the 5-HT
3
receptor
. British Journal of Pharmacology 169:6, pages 1228-1238.
Crossref
Crossref
M Yasuda, S Kato, N Yamanaka, M Iimori, K Matsumoto, D Utsumi, Y Kitahara, K Amagase, S Horie & K Takeuchi. (2013)
5-HT
3
receptor antagonists ameliorate 5-fluorouracil-induced intestinal mucositis by suppression of apoptosis in murine intestinal crypt cells
. British Journal of Pharmacology 168:6, pages 1388-1400.
Crossref
Crossref
Shinichi Kato. (2013) Role of Serotonin 5-HT<sub>3</sub> Receptors in Intestinal Inflammation. Biological and Pharmaceutical Bulletin 36:9, pages 1406-1409.
Crossref
Crossref
Christian Stratz, Harsharan S. Bhatia, Ravi Shankar Akundi, Thomas Nührenberg, Dietmar Trenk, Eduardo Muñoz & Bernd L. Fiebich. (2012) The anti-inflammatory effects of the 5-HT3 receptor antagonist tropisetron are mediated by the inhibition of p38 MAPK activation in primary human monocytes. International Immunopharmacology 13:4, pages 398-402.
Crossref
Crossref
Matthias F Seidel. (2012) Local injections of serotonin type-3 receptor antagonists as a therapeutic option in rheumatology. Future Medicinal Chemistry 4:6, pages 705-707.
Crossref
Crossref
Mariana Bravo-Hernández, Claudia Cervantes-Durán, Jorge Baruch Pineda-Farias, Paulino Barragán-Iglesias, Pedro López-Sánchez & Vinicio Granados-Soto. (2012) Role of peripheral and spinal 5-HT3 receptors in development and maintenance of formalin-induced long-term secondary allodynia and hyperalgesia. Pharmacology Biochemistry and Behavior 101:2, pages 246-257.
Crossref
Crossref
Azadeh Motavallian, Mohsen Minaiyan, Mohammad Rabbani, Parvin Mahzouni, Sasan Andalib, Alireza Abed & Mohammad Reza Babavalian. (2012)
Does Cisapride, as a 5HT
4
Receptor Agonist, Aggravate the Severity of TNBS-Induced Colitis in Rat?
. Gastroenterology Research and Practice 2012, pages 1-8.
Crossref
Crossref
Daisuke Setoguchi, Masataka Nakamura, Henry Yatsuki, Eizo Watanabe, Yoshihisa Tateishi, Tomoyuki Kuwaki & Shigeto Oda. (2011) Experimental examination of anti-inflammatory effects of a 5-HT3 receptor antagonist, tropisetron, and concomitant effects on autonomic nervous function in a rat sepsis model. International Immunopharmacology 11:12, pages 2073-2078.
Crossref
Crossref
S. C. R. Lummis, A. J. Thompson, M. Bencherif & H. A. Lester. (2011)
Varenicline Is a Potent Agonist of the Human 5-Hydroxytryptamine
3
Receptor
. Journal of Pharmacology and Experimental Therapeutics 339:1, pages 125-131.
Crossref
Crossref
Reza Rahimian, Ahmad Reza Dehpour, Gohar Fakhfouri, Mohammad Reza Khorramizadeh, Jean-Eric Ghia, Mohammad Seyedabadi, Antonio Caldarelli, Kazem Mousavizadeh, Mehdi Forouzandeh & Shahram Ejtemaei Mehr. (2011) Tropisetron upregulates cannabinoid CB1 receptors in cerebellar granule cells: Possible involvement of calcineurin. Brain Research 1417, pages 1-8.
Crossref
Crossref
Elena Magrini, Ildikò Szabò, Andrea Doni, Javier Cibella & Antonella Viola. (2011) Serotonin-Mediated Tuning of Human Helper T Cell Responsiveness to the Chemokine CXCL12. PLoS ONE 6:8, pages e22482.
Crossref
Crossref
Johannes Kapeller, Dorothee Möller, Felix Lasitschka, Frank Autschbach, Ruud Hovius, Gudrun Rappold, Michael Brüss, Michael D. Gershon & Beate Niesler. (2011) Serotonin receptor diversity in the human colon: Expression of serotonin type 3 receptor subunits 5-HT3C, 5-HT3D, and 5-HT3E. The Journal of Comparative Neurology 519:3, pages 420-432.
Crossref
Crossref
Jutta Walstab, Gudrun Rappold & Beate Niesler. (2010) 5-HT3 receptors: Role in disease and target of drugs. Pharmacology & Therapeutics 128:1, pages 146-169.
Crossref
Crossref
Nasrin Maleki-Dizaji, Tahereh Eteraf-Oskouei, Ashraf Fakhrjou, Seyyed Hadi Maljaie & Alireza Garjani. (2010) The effects of 5HT3 receptor antagonist granisetron on inflammatory parameters and angiogenesis in the air-pouch model of inflammation. International Immunopharmacology 10:9, pages 1010-1016.
Crossref
Crossref
S. Haub, Y. Ritze, I. Bergheim, O. Pabst, M. D. Gershon & S. C. Bischoff. (2010) Enhancement of intestinal inflammation in mice lacking interleukin 10 by deletion of the serotonin reuptake transporter. Neurogastroenterology & Motility 22:7, pages 826-e229.
Crossref
Crossref
Gohar Fakhfouri, Reza Rahimian, Ali Daneshmand, Arash Bahremand, Mohammad Reza Rasouli, Ahmad Reza Dehpour, Shahram Ejtemaei Mehr & Kazem Mousavizadeh. (2010) Granisetron ameliorates acetic acid-induced colitis in rats. Human & Experimental Toxicology 29:4, pages 321-328.
Crossref
Crossref
Kara Gross Margolis & Michael David Gershon. (2009) Neuropeptides and inflammatory bowel disease. Current Opinion in Gastroenterology 25:6, pages 503-511.
Crossref
Crossref
Sandra Combrink, Arevat Kostanian, Jutta Walstab, Martin Barann, Michael Brüss, Manfred Göthert & Heinz Bönisch. (2009) Characterization of the naturally occurring Arg344His variant of the human 5-HT3A receptor. Pharmacological Reports 61:5, pages 785-797.
Crossref
Crossref
Salvi Tushar Ramesh, Mohammed Asad, Sunil Samson Dhamanigi & V. Satya Prasad. (2009) Effect of central administration of ondansetron, a 5-hydroxytryptamine-3 receptor antagonist on gastric and duodenal ulcers. Fundamental & Clinical Pharmacology 23:3, pages 303-309.
Crossref
Crossref
K. Mousavizadeh, R. Rahimian, G. Fakhfouri, F. S. Aslani & P. Ghafourifar. (2009)
Anti-inflammatory effects of 5-HT
3
receptor antagonist, tropisetron on experimental colitis in rats
. European Journal of Clinical Investigation 39:5, pages 375-383.
Crossref
Crossref
Galina P. Kirillova, Rebecca J. Hrutkay, Michael R. Shurin, Galina V. Shurin, Irina L. Tourkova & Michael M. Vanyukov. (2008) Dopamine receptors in human lymphocytes: Radioligand binding and quantitative RT-PCR assays. Journal of Neuroscience Methods 174:2, pages 272-280.
Crossref
Crossref
Kazem Mousavizadeh, Thomas Stratz, Wolfgang Mueller & Bernd L Fiebich. (2008) 5-HT3 receptor antagonist for the treatment of tendinopathy. Nature Clinical Practice Rheumatology 4:7, pages E4-E4.
Crossref
Crossref
Cornelia Meineke, Mladen Vassilev Tzvetkov, Kristin Bokelmann, Elke Oetjen, Karen Hirsch-Ernst, Rolf Kaiser & Jürgen Brockmöller. (2008) Functional characterization of a -100_-102delAAG deletion-insertion polymorphism in the promoter region of the HTR3B gene. Pharmacogenetics and Genomics 18:3, pages 219-230.
Crossref
Crossref
Isabelle Cloëz-Tayarani & Jean-Pierre Changeux. (2007) Nicotine and serotonin in immune regulation and inflammatory processes: a perspective. Journal of Leukocyte Biology 81:3, pages 599-606.
Crossref
Crossref
María J. Núñez, José Balboa, Elena Rodrigo, Julio Brenlla, Mercedes González-Peteiro & Manuel Freire-Garabal. (2006) Effects of fluoxetine on cellular immune response in stressed mice. Neuroscience Letters 396:3, pages 247-251.
Crossref
Crossref
Laureano de la Vega, Eduardo Muñoz, Marco A. Calzado, Klaus Lieb, Eduardo Candelario-Jalil, Harald Gschaidmeir, Lothar Färber, Wolfgang Mueller, Thomas Stratz & Bernd L. Fiebich. (2005) The 5-HT3 receptor antagonist tropisetron inhibits T cell activation by targeting the calcineurin pathway. Biochemical Pharmacology 70:3, pages 369-380.
Crossref
Crossref